Guillermo Berbotto

1.7k total citations
10 papers, 252 citations indexed

About

Guillermo Berbotto is a scholar working on Rheumatology, Neurology and Infectious Diseases. According to data from OpenAlex, Guillermo Berbotto has authored 10 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 4 papers in Neurology and 1 paper in Infectious Diseases. Recurrent topics in Guillermo Berbotto's work include Systemic Lupus Erythematosus Research (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Guillermo Berbotto is often cited by papers focused on Systemic Lupus Erythematosus Research (4 papers), Peripheral Neuropathies and Disorders (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). Guillermo Berbotto collaborates with scholars based in Argentina, Colombia and United States. Guillermo Berbotto's co-authors include Bernardo A. Pons‐Estel, Graciela S. Alarcón, João Carlos Tavares Brenol, Emília Inoue Sato, Daniel Wojdyla, Luis H. Silveira, Eduardo Ferreira Borba, Loreto Massardo, Eloísa Bonfá and Hugo R. Scherbarth and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of the Rheumatic Diseases and Osteoporosis International.

In The Last Decade

Guillermo Berbotto

7 papers receiving 248 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guillermo Berbotto Argentina 5 210 88 45 45 35 10 252
Yukiko Takakuwa Japan 9 104 0.5× 68 0.8× 15 0.3× 16 0.4× 17 0.5× 35 219
G. Tokgöz Türkiye 10 179 0.9× 51 0.6× 21 0.5× 33 0.7× 170 4.9× 24 345
N. Györi Sweden 6 216 1.0× 104 1.2× 14 0.3× 59 1.3× 7 0.2× 12 238
Hector Arbillaga Canada 9 312 1.5× 165 1.9× 69 1.5× 61 1.4× 5 0.1× 11 344
B. Jamard France 10 196 0.9× 55 0.6× 20 0.4× 10 0.2× 7 0.2× 22 287
Yoshino Inoue Japan 9 128 0.6× 100 1.1× 12 0.3× 19 0.4× 6 0.2× 21 218
Francesco Natalucci Italy 9 246 1.2× 98 1.1× 30 0.7× 51 1.1× 3 0.1× 40 304
Elena Aurrecoechea Spain 11 200 1.0× 100 1.1× 26 0.6× 7 0.2× 9 0.3× 28 308
DD Gladman Canada 12 290 1.4× 192 2.2× 7 0.2× 57 1.3× 6 0.2× 19 341
M. André France 8 168 0.8× 31 0.4× 21 0.5× 21 0.5× 7 0.2× 19 402

Countries citing papers authored by Guillermo Berbotto

Since Specialization
Citations

This map shows the geographic impact of Guillermo Berbotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guillermo Berbotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guillermo Berbotto more than expected).

Fields of papers citing papers by Guillermo Berbotto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guillermo Berbotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guillermo Berbotto. The network helps show where Guillermo Berbotto may publish in the future.

Co-authorship network of co-authors of Guillermo Berbotto

This figure shows the co-authorship network connecting the top 25 collaborators of Guillermo Berbotto. A scholar is included among the top collaborators of Guillermo Berbotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guillermo Berbotto. Guillermo Berbotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Miranda, Gonzalo, et al.. (2024). P122 EXPLORING CARDIOVASCULAR RISK ENHANCERS IN WOMEN: EYE-OPENING FINDINGS TO RETHINK ASSESSMENT. Journal of Hypertension. 42(Suppl 3). e102–e102.
2.
Isnardi, C. A., Rosana Quintana, Karen Roberts, et al.. (2021). Características epidemiológicas y desenlaces de la infección por SARS-CoV-2 en pacientes con patologías reumáticas: primer reporte del registro argentino SAR-COVID. SHILAP Revista de lepidopterología. 32(1). 7–15.
3.
Brance, María Lorena, Bernardo A. Pons‐Estel, Guillermo Berbotto, et al.. (2020). Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling. Osteoporosis International. 32(4). 705–714. 8 indexed citations
4.
Brance, María Lorena, Silvana Di Gregorio, Bernardo A. Pons‐Estel, et al.. (2020). Prevalence of Sarcopenia and Whole-Body Composition in Rheumatoid Arthritis. JCR Journal of Clinical Rheumatology. 27(6S). S153–S160. 32 indexed citations
5.
Quintana, Rosana, Guillermo Pons‐Estel, Karen Roberts, et al.. (2019). Jaccoud’s arthropathy in SLE: findings from a Latin American multiethnic population. Lupus Science & Medicine. 6(1). e000343–e000343. 3 indexed citations
6.
Ugarte‐Gil, Manuel F., Daniel Wojdyla, Guillermo Pons‐Estel, et al.. (2017). Remission and Low Disease Activity Status (LDAS) protect lupus patients from damage occurrence: data from a multiethnic, multinational Latin American Lupus Cohort (GLADEL). Annals of the Rheumatic Diseases. 76(12). 2071–2074. 70 indexed citations
7.
Pons‐Estel, Guillermo, Daniel Wojdyla, Manuel F. Ugarte‐Gil, et al.. (2017). 192 Protective effect of antimalarials on the risk of damage accrual in systemic lupus erythematosus. A90.1–A90.
8.
Shinjo, Samuel Katsuyuki, Eloísa Bonfá, Daniel Wojdyla, et al.. (2010). Antimalarial treatment may have a time‐dependent effect on lupus survival: Data from a multinational Latin American inception cohort. Arthritis & Rheumatism. 62(3). 855–862. 134 indexed citations
9.
Pons‐Estel, Bernardo A., et al.. (1999). Vasculitis sistémicas: toma de decisiones. 336–336. 1 indexed citations
10.
Berbotto, Guillermo, et al.. (1993). [Antipyretic effect of indomethacin vs aspirin in fever of tumor origin].. PubMed. 53(1). 35–8. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yukiko Takakuwa Breakdown of academic impact, for papers by G. Tokgöz Breakdown of academic impact, for papers by N. Györi Breakdown of academic impact, for papers by Hector Arbillaga Breakdown of academic impact, for papers by B. Jamard Breakdown of academic impact, for papers by Yoshino Inoue Breakdown of academic impact, for papers by Francesco Natalucci Breakdown of academic impact, for papers by Elena Aurrecoechea Breakdown of academic impact, for papers by DD Gladman Breakdown of academic impact, for papers by M. André
Rankless by CCL
2026